08:30-08:50 |
Registration |
이대우 (대한부인종양학회 사무총장) |
Convention hall |
08:50-09:00 |
개회사 및 명예회원증 수여 |
김영태 (대한부인종양학회 회장) |
Session I-1 Keynote Lecture I |
좌장: 유희석 (아주의대) 김영탁 (울산의대) |
09:00-09:25 |
Recurrent ovarian cancer: when does surgery make a difference?  |
Ginger J. Gardner (Memorial Sloan Kettering Cancer Center, USA) |
|
Designated discussion |
임가원 (동국의대) |
09:25-09:50 |
Overcoming homologous recombination proffciency in ovarian cancer  |
Aikou Okamoto (Jikei University, Japan) |
|
Designated discussion |
최윤진 (가톨릭의대) |
Session I-2 Keynote Lecture II |
좌장: 김재원 (서울의대) 이철민 (차의대) |
09:50-10:15 |
Recent progress of precision medicine in ovarian cancer  |
Andreas du Bois (Kliniken Essen-Mitte, Germany |
|
Designated discussion |
박수진 (서울의대) |
10:15-10:40 |
Bio- and GenomeBank Denmark (RBGB) including the danish cancerbiobank  |
Estrid Hoegdall (University of Copenhagen, Denmark) |
|
Designated discussion |
유상영 (원자력병원) |
10:40-11:00 |
Coffee break |
Session II-1 Plenary session I |
좌장: 김승철 (이화의대) 조치흠 (계명의대) |
11:00-11:10 |
Lymphadenectomy in clinically early epitheLial ovarian cancer and survival analysis: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion (GORILLA) group (GORILLA-3002) |
양은정 (건국의대) |
11:10-11:20 |
Optimum selection criteria for secondary cytoreductive surgery in patients with recurrent ovarian cancer: A multicenter study from the Gynecologic Oncology Research Investigators coLLaborAtion (GORILLA) group (GORILLA-3001)) |
손주혁 (아주의대) |
11:20-11:30 |
Selection Criteria for Omitting interval debulking suRgery after nEoadjuvant chemotherapy for advanced high-grade serous carcinoma of the ovary: KGOG OVsurg-2016/SCORE study |
박수진 (서울의대) |
11:30-11:40 |
Designated discussion |
조한별 (연세의대) 이대형 (영남의대) 이원무 (한양의대) |
Session II-2 Plenary session II |
좌장: 배덕수 (을지의대) 최중섭 (한양의대) |
11:40-11:50 |
A nomogram to predict anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer |
김지현 (국립암센터) |
11:50-12:00 |
Optimal management of platinum-sensitive relapsed ovarian clear cell carcinoma: A multi-center study in Korea |
김세익 (서울의대) |
12:00-12:10 |
Prognostic impact of erythropoietin-stimulating agents during front-line chemotherapy in patients with ovarian cancer: A Korea multicenter cohort study |
심승혁 (건국의대) |
12:10-12:20 |
Designated discussion |
이선주 (건국의대) 신진우 (가천의대) 남은지 (연세의대) |
Luncheon symposium |
좌장: 남주현 (울산의대) 김용범 (서울의대) |
12:20-12:40 |
A new powder-type hemostatic agent in gynecologic oncologic surgical procedures |
박성택 (한림의대) |
12:40-13:00 |
The incorporation of HPV testing for cervical cancer screening: The What, Why, and How?  |
Warner K. Huh (University of Alabama at Birmingham, USA) |
13:00-13:30 |
Lunch |
Symposium I- Convention hall |
Session Ⅲ-1 Focused plenary session Ⅰ |
좌장: 김재욱 (연세의대) 남궁성은 (가톨릭의대) |
13:30-13:40 |
Clinicopathologic and protein markers distinguishing the “polymerase epsilon exonuclease” from the “copy number low” subtype of endometrial cancer |
김기동 (서울의대) |
13:40-13:50 |
Ten-year survival for patients with epithelial ovarian cancer treated with consolidation hyperthermic intraperitoneal chemotherapy |
유지근 (가톨릭의대) |
13:50-14:00 |
Genome-based molecular classification and clinicopathological features in korean patients |
한경희 (차의대) |
14:00-14:10 |
Anticancer effect of fenbendazole according to drug delivery mode in ovarian cancer models |
장지선 (성균관의대) |
14:10-14:20 |
Open versus minimally invasive radical hysterectomy in early-stage cervical cancer with usual type adenocarcinoma and adenosquamous carcinoma: A two-center retrospective study with central pathology review |
김여래 (서울의대) |
Session Ⅲ-2 Focused plenary session Ⅱ |
좌장: 강순범 (서울의대) 허수영 (가톨릭의대) |
14:20-14:30 |
Development and validation of a prediction model for successful complete cytoreduction at primary cytoreductive surgery for advanced ovarian cancer by integrating of 18F-FDG PET/CT parameters and CA-125 |
김준환 (서울의대) |
14:30-14:40 |
Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer |
전정은 (성균관의대) |
14:40-14:50 |
Evaluation of anti-cancer ecacy of siRNA targeting HPV16 E6 and E7 combined with cisplatin in cervical cancer cells xenograft mouse model |
박민정 (울산의대) |
14:50-15:00 |
Plasma-activated medium inhibits cancer stem cell-like properties and exhibits a synergistic effect in combination with cisplatin in ovarian cancer |
권병수 (경희의대) |
15:00-15:10 |
Anti-cancer activity of cabozatinib and temozolomide and their ecacy for uterine leiomyosarcoma in a mouse xenograft mode |
노준호 (성균관의대) |
15:10-15:30 |
Coffee break |
Session Ⅳ 부인암 수술동의서 개발 및 HPV 연구용역사업 보고 |
좌장: 이종민 (경희의대) 이재관 (고려의대) |
15:30-15:45 |
의사의 설명의무와 의료분쟁 |
현두륜 변호사 (법무법인 세승) |
15:45-15:55 |
수술동의서 소개 |
심승혁 (건국의대) |
15:55-16:05 |
Discussion |
장하균 (고려의대) |
16:05-16:20 |
국가암검진 자궁경부암 선별검사에서 인유두종바이러스 DNA검사의 비용-효과 분석 |
김현규 (연세의대 예방의학교실) |
16:20-16:30 |
Discussion |
정대훈 (인제의대) |
Symposium II- Crystal hall 1 |
Session Ⅲ-3 Focused plenary session Ⅲ |
좌장: 김병기 (성균관의대) 성석주 (차의대) |
13:30-13:40 |
Effect of post-operative hormone replacement therapy on survival in women with ovarian cancer |
이방현 (인하의대) |
13:40-13:50 |
Efficacy and potential pitfalls of pre-operative PET-CT in endometrial cancer patients undergoing one-step and two-step sentinel lymph node mapping: Is PET-CT negative really node negative? |
김유나 (연세의대) |
13:50-14:00 |
Survival outcomes from laparoscopic radical hysterectomy in conizationskipped, stage IB1 cervical cancer |
임현지 (서울의대) |
14:00-14:10 |
Role of glycine decarboxylase in chemo-resistant ovarian cancer cells |
이승미 (계명의대) |
14:10-14:20 |
Is minimally invasive surgery safe for cervical cancer patients with a diameter of less than 2 cm? |
공태욱 (아주의대) |
Session Ⅲ-4 Focused plenary session Ⅳ |
좌장: 김용만 (울산의대) 김태진 (건국의대) |
14:20-14:30 |
Incidence of cervical intraepithelial neoplasia in republic of korea: A nationwide cross-sectional study 2009-2018 |
경민선 (한림의대) |
14:30-14:40 |
A phase II trial of docetaxel/cisplatin chemotherapy followed by pelvic radiation therapy in patients with high-risk endometrial carcinoma after staging surgery |
조윤정 (울산의대) |
14:40-14:50 |
Role of klotho as a modulator of oxidative stress associated with ovarian tissue cryopreservation |
이상훈 (고려의대) |
14:50-15:00 |
Comparison of outcome of sentinel node biopsy vs. Lymphadenectomy in endometrial cancer: A propensity-matched data |
이다혜 (연세의대) |
15:00-15:10 |
Enhanced susceptibility to cervical cancer in korean women with elevated serum gamma-glutamyltransferase levels: A nationwide population-based cohort study |
설애란 (고려의대) |
15:10-15:30 |
Coffee break |
Session Ⅴ Biomarkers and application in precision medicine for gynecologic cancers |
좌장: 유종우 (국립암센터 병리학교실) 박노현 (서울의대) 김재훈 (연세의대) |
15:30-15:50 |
Biomarkers for molecular classification of endometrial cancer |
김현수 (성균관의대 병리학교실) |
15:50-16:10 |
Biomarkers and HRD for ovarian cancer |
김효진 (서울의대 병리학교실) |
16:10-16:30 |
Biomarkers for uterine sarcoma and rare tumors |
조화진 (인제의대 병리학교실) |
Symposium Ⅲ- Crystal hall 2 |
Session Ⅲ-5 Focused plenary session Ⅴ |
좌장: 남계현 (순천향의대) 장석준 (아주의대) |
13:30-13:40 |
Prediction of platinum-based chemotherapy sensitivity for epithelial ovarian cancer by magnetic resonance-based radiomics |
송희경 (가톨릭의대) |
13:40-13:50 |
Trends in incidence and survival of patients with vulvar cancer in an asian country: analysis of the korean central cancer registry 1999–2018 |
조성실 (한양의대) |
13:50-14:00 |
Recurrence prediction of endometrial cancer patients with various machine learning technique |
신원교 (충남의대) |
14:00-14:10 |
Anti-tumor effects of lenvatinib plus anti-PD-1 in syngeneic murine cervical cancer models |
강지식 (울산의대) |
14:10-14:20 |
The expression of HOXA-AS3 induces tumor progression through the epithelialmesenchymal transition pathway in epithelial ovarian cancer |
어경진 (연세의대) |
Session Ⅲ-6 Focused plenary session Ⅵ |
좌장: 김기형 (부산의대) 박철민 (제주의대) |
14:20-14:30 |
Clinical characteristics and desensitization protocol of chemotherapy-induced hypersensitivity reactions in patients with gynecologic cancer |
김승호 (울산의대) |
14:30-14:40 |
Impact of neoadjuvant chemotherapy cycles in patients with advanced epithelial ovarian cancer: meta-analysis and systemic review |
조현웅 (고려의대) |
14:40-14:50 |
Identification of immune-related biomarkers associated with BRCA mutations in epithelial ovarian cancer |
김효선 (연세의대) |
14:50-15:00 |
Lymphedema in cervical cancer survivor: a nationwide cohort study |
이수정 (가톨릭의대) |
15:00-15:10 |
Multiplexed immunohistochemistry for immune profiling in cervical cancer according to tumor budding status |
김종미 (경북의대) |
15:10-15:30 |
Coffee break |
Session Ⅲ-7 Focused plenary session VII |
좌장: 이정원 (성균관의대) 김상운 (연세의대) |
15:30-15:40 |
DKK3, downregulated in ovarian cancer, enhanced paclitaxel susceptibility by inhibiting the P-glycoprotein |
이은주 (중앙의대) |
15:40-15:50 |
Effect of quality control program in surgical management of early cervical cancer |
김보라 (이화의대) |
15:50-16:00 |
CD8α+ dendritic cells enhance the antitumor and immune activities against syngeneic and orthotopic murine ovarian cancer models |
남소현 (울산의대) |
16:00-16:10 |
Robotic single-site radical hysterectomy for early cervical cancer: A single center experience of 5 years |
장태규 (계명의대) |
16:10-16:20 |
Prediction of lymphovascular space invasion in patients with endometrial cancer |
김상일 (가톨릭의대) |
16:20-16:30 |
Neutrophil–lymphocyte and platelet–lymphocyte ratios in preoperative differential diagnosis of benign, borderline, and malignant ovarian tumors |
유정민 (대구가톨릭의대) |
Convention hall |
Session Ⅵ Tumor board |
좌장: 김대연 (울산의대) 이택상 (서울의대) |
16:40-17:20 |
Endometrial cancer with suspicious lymph node metastasis |
박정열 (울산의대) |
|
Panel discussion |
김태훈 (서울의대) 이유영 (성균관의대) 김미경 (이화의대) |
17:20 |
폐회사 |
김영태 (대한부인종양학회 회장) |
18:30 |
신풍호월학술상 & JGO Best Paper & Reviewer Award 시상 및 만찬 |